follow us on
reach us on app store
News18 » Videos » News18 Shorts

PIL in SC against Ranbaxy for manufacturing adulterated drugs

Jun 05, 2013 09:22 AM IST Business Business
Share

New Delhi: A Public-interest litigation (PIL) has been moved in the Supreme Court against Ranbaxy Pharma.

The PIL is seeking prosecution of all Ranbaxy directors and sealing of its manufacturing units at Paonta Sahib and Devas.

This was based on Ranbaxy USA's 500 million dollar settlement with the US for making and selling aulterated drugs for over four years. Earlier in May, Ranbaxy had pleaded guilty to felony charges.